Details for 2017797002
Up to date per 01.04.2026
Actions
Details for 2017797002
Granted/Registered
European Patent
27.02.2019 A
28.12.2022 B1
13.05.2016
US
201662336441 P
22.08.2016
US
201662378106 P
07.09.2016
US
201662384590 P
03.02.2017
US
201762454612 P
C07K 14/075 20060101AFI20190828BHEP
Owner
4D Molecular Therapeutics Inc.5980 Horton Street Suite 460 Emeryville, CA 94608US
Representative
No representatives present
Inventor
KIRN, David, H.5980 Horton Street Suite 460 Emeryville, CA 94608US
KOTTERMAN, Melissa5980 Horton Street Suite 460 Emeryville, CA 94608US
SCHAFFER,David5980 Horton Street Suite 460 Emeryville, CA 94608US
Information about Fees